Clinical trials
Headache Disorders, Primary trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 5 |
| Recruiting | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankara City Hospital Bilkent | 1 |
| Antonio Francesco Urbino | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Children's Mercy Hospital Kansas City | 1 |
| Danish Headache Center | 1 |
| Federal University of São Paulo | 1 |
| Hacettepe University | 1 |
| Happyr Ltd | 1 |
| Korean Medicine Hospital of Pusan National University | 1 |
| Leiden University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Headache Disorders, Primary | 17 |
| Migraine Disorders | 9 |
| Headache | 4 |
| Headache Disorders | 4 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Migraine without Aura | 2 |
| Neck Pain | 2 |
| Nervous System Diseases | 2 |
| Pain | 2 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.